Gastroesophageal reflux disease increases predisposition to severe COVID‐19: Insights from integrated Mendelian randomization and genetic analysis
2025

GERD and Severe COVID-19 Risk

Sample size: 602604 publication 10 minutes Evidence: high

Author Information

Author(s): Pan Jingjing, Li Jianhua

Primary Institution: Zhejiang Provincial Centers for Disease Control and Prevention

Hypothesis

Does gastroesophageal reflux disease (GERD) increase the risk of severe COVID-19?

Conclusion

Genetically determined GERD may increase susceptibility to hospitalized and severe COVID-19.

Supporting Evidence

  • GERD showed a significant positive genetic correlation with hospitalized COVID-19.
  • The MR analysis indicated a causal effect of GERD on COVID-19 outcomes.
  • Shared genomic loci were identified between GERD and COVID-19.
  • Colocalization analysis showed significant correlations between GWAS and eQTL abnormalities.
  • Molecular pathway analysis indicated GERD may influence COVID-19 through immune-related pathways.

Takeaway

People with GERD might get sicker if they catch COVID-19 because of their genes.

Methodology

The study used Mendelian randomization and genetic analysis to explore the relationship between GERD and COVID-19.

Potential Biases

Potential bias from pleiotropy in the genetic data.

Limitations

The study focused only on genetic factors and did not consider environmental influences.

Participant Demographics

Participants were of European descent.

Statistical Information

P-Value

9.17e−12

Confidence Interval

1.27–1.44

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1111/ahg.12584

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication